| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 25, 2005
From the Department for Prevention and Health Services Research (J.N.S., M.L.L.v.G., C.A.B.), National Institute of Public Health and the Environment, Bilthoven; the Department of Health Organization Policy and Economics (S.M.A.A.E., A.J.H.A.A.), Maastricht University, Maastricht; iRv (S.M.A.A.E.), Institute for Rehabilitation Research, Hoensbroek; and the Department of Social Medicine (G.A.M.v.d.B.), Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands. * To whom correspondence should be addressed. E-mail: jeroen.struijs{at}rivm.nl.
Background and Purpose--In the near future, the number of stroke patients and their related healthcare costs are expected to rise. The purpose of this study was to estimate this expected increase in stroke patients in the Netherlands. We sought to determine what the future developments in the number of stroke patients due to demographic changes and trends in the prevalence of smoking and hypertension in terms of the prevalence, incidence, and potential years of life lost might be. Methods--A dynamic, multistate life table was used, which combined demographic projections and existing stroke morbidity and mortality data. It projected future changes in the number of stroke patients in several scenarios for the Dutch population for the period 2000 to 2020. The model calculated the annual number of new patients by age and sex by using incidence rates, defined by age, sex, and major risk factors. The change in the annual number of stroke patients is the result of incident cases minus mortality numbers. Results--Demographic changes in the population suggest an increase of 27% in number of stroke patients per 1000 in 2020 compared with 2000. Extrapolating past trends in the prevalence of smoking behavior, hypertension, and stroke incidence resulted in an increase of 4%. Conclusions--The number of stroke patients in the Netherlands will rise continuously until the year 2020. Our study demonstrates that a large part of this increase in the number of patients is an inevitable consequence of the aging of the population.
Revised on April 19, 2005
Accepted on May 13, 2005
Modeling the Future Burden of Stroke in the Netherlands. Impact of Aging, Smoking, and Hypertension
Jeroen N. Struijs MSc*;
This article has been cited by other articles:
![]() |
J. T. Becker, L. Kingsley, J. Mullen, B. Cohen, E. Martin, E. N. Miller, A. Ragin, N. Sacktor, O. A. Selnes, B. R. Visscher, et al. Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men Neurology, October 20, 2009; 73(16): 1292 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurth and M.-G. Bousser Stroke in Women: An Evolving Topic Stroke, April 1, 2009; 40(4): 1027 - 1028. [Full Text] [PDF] |
||||
![]() |
W. Dai, O. L. Lopez, O. T. Carmichael, J. T. Becker, L. H. Kuller, and H. M. Gach Abnormal Regional Cerebral Blood Flow in Cognitively Normal Elderly Subjects With Hypertension Stroke, February 1, 2008; 39(2): 349 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A.M. Jacobs-van der Bruggen, G. Bos, W. J. Bemelmans, R. T. Hoogenveen, S. M. Vijgen, and C. A. Baan Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk: Results from a modeling study Diabetes Care, January 1, 2007; 30(1): 128 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Kolominsky-Rabas, P. U. Heuschmann, D. Marschall, M. Emmert, N. Baltzer, B. Neundorfer, O. Schoffski, K. J. Krobot, and for the CompetenceNet Stroke Lifetime Cost of Ischemic Stroke in Germany: Results and National Projections From a Population-Based Stroke Registry: The Erlangen Stroke Project Stroke, May 1, 2006; 37(5): 1179 - 1183. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |